SMARCB1 and rhabdoid tumor of the kidney: <h4>Background</h4>Rhabdoid tumor of the kidney (RTK) is a highly aggressive pediatric malignancy characterized by biallelic <i>SMARCB1</i> loss, resulting in aberrant MYC pathway activation and cell cycle regulation.